pioglitazone

pioglitazone /pi·o·glit·a·zone/ (pi″o-glit´ah-zōn) an antidiabetic agent that decreases insulin resistance in the peripheral tissues and liver; used as the hydrochloride salt in the treatment of type 2 diabetes mellitus.

pioglitazone,

an oral antidiabetic.

indication It is used to treat stable type 2 diabetes mellitus.

contraindications Lactation, diabetic ketoacidosis, and known hypersensitivity to this drug prohibit its use. It is also contraindicated in children.

adverse effects Common adverse effects include myalgia, sinusitis, upper respiratory infection, pharyngitis, headache, and aggravated diabetes mellitus.

pioglitazone [pi″o-glit´ah-zōn]

an agent used in treatment of type 2 diabetes mellitis, decreasing insulin resistance in the peripheral tissues and liver, used orally as the hydrochloride salt.

pioglitazone

Actos^® Endocrinology An oral antidiabetic that ↓ insulin resistance, used to manage type 2 DM; it inhibits hepatic gluconeogenesis, and improves glycemic control while ↓ circulating insulin Adverse effects Edema, ↑ URIs, headaches, myalgias, sinusitis. See Diabetes mellitus.

Mentioned in	?		References in periodicals archive	?		Medical browser	?		Full browser	?
Actos Antidiabetic Drugs insulin resistance Januvia pioglitazone hydrochloride sitagliptin phosphate	Other oral agents can reduce insulin resistance (metformin, pioglitazone, and rosiglitazone) or slow the absorption of sugars from the intestine (acarbose and miglitol). Diabetes Causes, Prevention and Treatment Part 2 by john daniel rivera / Health, general community Among older patients with diabetes, pioglitazone is associated with a significantly lower risk of heart failure and death than is rosiglitazone," they wrote. Drug worries by Evening Chronicle (Newcastle, England) With the help of prescription records, boffins identified nearly 40,000 patients aged 66 years and older who started treatment with either rosiglitazone or pioglitazone between April 2002 and March 2008. Diabetes drug 'increases heart failure risk' by Asian News International	pinnation pinning pinniped pinocyte pinocytosis pinosome pinprick pinprick test Pins' syndrome Pinsaun pinscher pint pinta pinta fever pinto pinup procedure Pinus Pinwheel Pattern pinworm pinworm infection pinworm tape test Pinzgau Pinzgauer PIO 2 pio- pioglitazone pioglitazone hydrochloride pion PIOPED Piophila casei PIP pipe cleaner pipe fast pipe tobacco pipecolic acid pipecurium pipecuronium pipecuronium bromide Pipeline Pipelle pipemidic acid Piper forceps Piper longum Piper Methysticum Piper Nigrum piperacetazine piperacillin piperacillin sodium piperacillin sodium and tazobactam sodium piperacillin-tazobactam piperazine	PIO 2 Pío Baroja Pio Gianotti PIO Mode Pio Pico Adobe Pio Pico Casa Pio pico mansion Pio Pico State Historic Park Pío Pico State Historic Park Pio, Louis Pio, Padre pio- PIOA PIOB Pìobaireachd Pìobaireachd Piobert lines PIOC PIOCS PIOCS PIOD PIOF PIOFM PIOFS PIOG pioglitazone Pioglitazone hydrochloride Pioglitazone in Prevention of Diabetes PIOH PIOJ PIOL piolet piolets Piolink Network Load Balancer PIOM Piombino Piombino, Italy Piombo, Sebastiano del PIOMT pion pion pion pion pion bremsstrahlung pion condensate pion double-charge exchange Pion Generator for Medical Irradiation Pion Linear Accelerator PIONA Pionculo List Pioned Pioned Pioned pioneer pioneer pioneer

Mentioned in

References in periodicals archive

Medical browser

Full browser

Actos
Antidiabetic Drugs
insulin resistance
Januvia
pioglitazone hydrochloride
sitagliptin phosphate

Other oral agents can reduce insulin resistance (metformin, pioglitazone, and rosiglitazone) or slow the absorption of sugars from the intestine (acarbose and miglitol).

Diabetes Causes, Prevention and Treatment Part 2 by john daniel rivera / Health, general community

Among older patients with diabetes, pioglitazone is associated with a significantly lower risk of heart failure and death than is rosiglitazone," they wrote.

Drug worries by Evening Chronicle (Newcastle, England)

With the help of prescription records, boffins identified nearly 40,000 patients aged 66 years and older who started treatment with either rosiglitazone or pioglitazone between April 2002 and March 2008.

Diabetes drug 'increases heart failure risk' by Asian News International